0001415889-24-004493.txt : 20240220
0001415889-24-004493.hdr.sgml : 20240220
20240220193511
ACCESSION NUMBER: 0001415889-24-004493
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240213
FILED AS OF DATE: 20240220
DATE AS OF CHANGE: 20240220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Phillips Andrew John
CENTRAL INDEX KEY: 0001921956
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39247
FILM NUMBER: 24655867
MAIL ADDRESS:
STREET 1: C/O CORMORANT ASSET MANAGEMENT, LLP
STREET 2: 200 CLARENDON STREET, FL 52
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Enliven Therapeutics, Inc.
CENTRAL INDEX KEY: 0001672619
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-647-8519
MAIL ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: IMARA Inc.
DATE OF NAME CHANGE: 20160419
4/A
1
form4a-02212024_120239.xml
X0508
4/A
2024-02-13
2024-02-15
0001672619
Enliven Therapeutics, Inc.
ELVN
0001921956
Phillips Andrew John
C/O ENLIVEN THERAPEUTICS, INC.
6200 LOOKOUT ROAD
BOULDER
CO
80301
true
false
false
false
0
Stock Option (right to buy)
14.85
2024-02-13
4
A
0
23364
0
A
2034-02-13
Common Stock
23364
23364
D
The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant.
100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date.
/s/ Ben Hohl, by power of attorney
2024-02-20